Digitalization in biopharmaceutical downstream processes
Biopharmaceuticals are highly valued for their ability to specifically and efficiently treat diseases. However, they require rigorous purification that involves complex unit operations to reach the levels of purity necessitated for use in patients. Maintaining this purity while recovering as much of the valuable biopharmaceutical as possible is the core challenge in biopharmaceutical downstream pr
